MOG and Encephalopathy: Antibodies against the N-methyl-D-Aspartate receptor (NMDA-R-IgG) are the most commonly encountered in association with MOG-IgG, and patients typically present with encephalopathy, seizures, and leptomeningeal enhancement (119, 120).